Jayaraj RL, Azimullah S, Beiram R, Jalal FY, Rosenberg GA (2019) Neuroinflammation: friend and foe for ischemic stroke. J Neuroinflammation 16:142. https://doi.org/10.1186/s12974-019-1516-2

Article  PubMed  PubMed Central  Google Scholar 

Qin C, Yang S, Chu YH, Zhang H, Pang XW, Chen L, Zhou LQ, Chen M et al (2022) Signaling pathways involved in ischemic stroke: molecular mechanisms and therapeutic interventions. Signal Transduct Target Ther 7:215. https://doi.org/10.1038/s41392-022-01064-1

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lambertsen KL, Finsen B, Clausen BH (2019) Post-stroke inflammation-target or tool for therapy? Acta Neuropathol 137:693–714. https://doi.org/10.1007/s00401-018-1930-z

Article  PubMed  Google Scholar 

Korn T, Bettelli E, Oukka M, Kuchroo VK (2009) IL-17 and Th17 cells. Annu Rev Immunol 27:485–517. https://doi.org/10.1146/annurev.immunol.021908.132710

Article  CAS  PubMed  Google Scholar 

Fu J, Huang Y, Bao T, Liu C, Liu X, Chen X (2022) The role of Th17 cells/IL-17A in AD, PD, ALS and the strategic therapy targeting on IL-17A. J Neuroinflammation 19:98. https://doi.org/10.1186/s12974-022-02446-6

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cosmi L, Santarlasci V, Maggi L, Liotta F, Annunziato F (2014) Th17 plasticity: pathophysiology and treatment of chronic inflammatory disorders. Curr Opin Pharmacol 17:12–16. https://doi.org/10.1016/j.coph.2014.06.004

Article  CAS  PubMed  Google Scholar 

Waisman A, Hauptmann J, Regen T (2015) The role of IL-17 in CNS diseases. Acta Neuropathol 129:625–637. https://doi.org/10.1007/s00401-015-1402-7

Article  CAS  PubMed  Google Scholar 

Stockinger B, Veldhoen M (2007) Differentiation and function of Th17 T cells. Curr Opin Immunol 19:281–286. https://doi.org/10.1016/j.coi.2007.04.005

Article  CAS  PubMed  Google Scholar 

Mangan PR, Harrington LE, O’quinn DB, Helms WS, Bullard DC, Elson CO, Hatton RD, Wahl SM et al (2006) Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 441:231–234. https://doi.org/10.1038/nature04754

Article  CAS  PubMed  Google Scholar 

Weaver CT, Elson CO, Fouser LA, Kolls JK (2013) The Th17 pathway and inflammatory diseases of the intestines, lungs, and skin. Annu Rev Pathol 8:477–512. https://doi.org/10.1146/annurev-pathol-011110-130318

Article  CAS  PubMed  Google Scholar 

Wu X, Wang J, Liu K, Zhu J, Zhang HL (2016) Are Th17 cells and their cytokines a therapeutic target in Guillain-Barre syndrome? Expert Opin Ther Targets 20:209–222. https://doi.org/10.1517/14728222.2016.1086751

Article  CAS  PubMed  Google Scholar 

Harbour SN, Ditoro DF, Witte SJ (2020) T(H)17 cells require ongoing classic IL-6 receptor signaling to retain transcriptional and functional identity. 5. https://doi.org/10.1126/sciimmunol.aaw2262

Yang L, Anderson DE, Baecher-Allan C, Hastings WD, Bettelli E, Oukka M, Kuchroo VK, Hafler DA (2008) IL-21 and TGF-beta are required for differentiation of human T(H)17 cells. Nature 454:350–352. https://doi.org/10.1038/nature07021

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jiang P, Zheng C, Xiang Y, Malik S, Su D, Xu G, Zhang M (2022) The involvement of TH17 cells in the pathogenesis of IBD. Cytokine Growth Factor Rev. https://doi.org/10.1016/j.cytogfr.2022.07.005

Bhaumik S, Basu R (2017) Cellular and molecular dynamics of Th17 differentiation and its developmental plasticity in the intestinal immune response. Front Immunol 8:254. https://doi.org/10.3389/fimmu.2017.00254

Article  CAS  PubMed  PubMed Central  Google Scholar 

Beringer A, Noack M, Miossec P (2016) IL-17 in chronic inflammation: from discovery to targeting. Trends Mol Med 22:230–241. https://doi.org/10.1016/j.molmed.2016.01.001

Article  CAS  PubMed  Google Scholar 

Starnes T, Robertson MJ, Sledge G, Kelich S, Nakshatri H, Broxmeyer HE, Hromas R (2001) Cutting edge: IL-17F, a novel cytokine selectively expressed in activated T cells and monocytes, regulates angiogenesis and endothelial cell cytokine production. J Immunol 167:4137–4140. https://doi.org/10.4049/jimmunol.167.8.4137

Article  CAS  PubMed  Google Scholar 

Patel DD, Kuchroo VK (2015) Th17 cell pathway in human immunity: lessons from genetics and therapeutic interventions. Immunity 43:1040–1051. https://doi.org/10.1016/j.immuni.2015.12.003

Article  CAS  PubMed  Google Scholar 

Gaffen SL (2009) Structure and signalling in the IL-17 receptor family. Nat Rev Immunol 9:556–567. https://doi.org/10.1038/nri2586

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang Q, Liao Y, Liu Z, Dai Y, Li Y, Li Y, Tang Y (2021) Interleukin-17 and ischaemic stroke. Immunology 162:179–193. https://doi.org/10.1111/imm.13265

Article  CAS  PubMed  Google Scholar 

Li Q, Ding S, Wang YM, Xu X, Shen Z, Fu R, Liu M, Hu C et al (2017) Age-associated alteration in Th17 cell response is related to endothelial cell senescence and atherosclerotic cerebral infarction. Am J Transl Res 9:5160–5168

CAS  PubMed  PubMed Central  Google Scholar 

Yu S, Cui W, Han J, Chen J, Tao W (2022) Longitudinal change of Th1, Th2, and Th17 cells and their relationship between cognitive impairment, stroke recurrence, and mortality among acute ischemic stroke patients. J Clin Lab Anal 36:e24542. https://doi.org/10.1002/jcla.24542

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dolati S, Ahmadi M, Khalili M, Taheraghdam AA, Siahmansouri H, Babaloo Z, Aghebati-Maleki L, Jadidi-Niaragh F et al (2018) Peripheral Th17/Treg imbalance in elderly patients with ischemic stroke. Neurol Sci 39:647–654. https://doi.org/10.1007/s10072-018-3250-4

Article  PubMed  Google Scholar 

Lu T, Ma L, Xu Q, Wang X (2022) Blood Th17 cells and IL-17A as candidate biomarkers estimating the progression of cognitive impairment in stroke patients. J Clin Lab Anal 36:e24581. https://doi.org/10.1002/jcla.24581

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li GZ, Zhong D, Yang LM, Sun B, Zhong ZH, Yin YH, Cheng J, Yan BB et al (2005) Expression of interleukin-17 in ischemic brain tissue. Scand J Immunol 62:481–486. https://doi.org/10.1111/j.1365-3083.2005.01683.x

Article  CAS  PubMed  Google Scholar 

Wang H, Zhong D, Chen H, Jin J, Liu Q, Li G (2019) NLRP3 inflammasome activates interleukin-23/interleukin-17 axis during ischaemia-reperfusion injury in cerebral ischaemia in mice. Life Sci 227:101–113. https://doi.org/10.1016/j.lfs.2019.04.031

Article  CAS  PubMed  Google Scholar 

Backes FN, De Souza A, Bianchin MM (2021) IL-23 and IL-17 in acute ischemic stroke: correlation with stroke scales and prognostic value. Clin Biochem 98:29–34. https://doi.org/10.1016/j.clinbiochem.2021.09.003

Article  CAS  PubMed  Google Scholar 

Luo Y, Zhou Y, Xiao W, Liang Z, Dai J, Weng X, Wu X (2015) Interleukin-33 ameliorates ischemic brain injury in experimental stroke through promoting Th2 response and suppressing Th17 response. Brain Res 1597:86–94. https://doi.org/10.1016/j.brainres.2014.12.005

Article  CAS  PubMed  Google Scholar 

Guo Y, Chen X, Li D, Liu H, Ding Y, Han R, Shi Y, Ma X (2018) PR-957 mediates neuroprotection by inhibiting Th17 differentiation and modulating cytokine production in a mouse model of ischaemic stroke. Clin Exp Immunol 193:194–206. https://doi.org/10.1111/cei.13132

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ji E, Lee S (2021) Antibody-based therapeutics for atherosclerosis and cardiovascular diseases. Int J Mol Sci 22.https://doi.org/10.3390/ijms22115770

Liu ZD, Wang L, Lu FH, Pan H, Zhao YX, Wang SJ, Sun SW, Li CL et al (2012) Increased Th17 cell frequency concomitant with decreased Foxp3+ Treg cell frequency in the peripheral circulation of patients with carotid artery plaques. Inflamm Res 61:1155–1165. https://doi.org/10.1007/s00011-012-0510-2

Article  CAS  PubMed  Google Scholar 

Hot A, Lenief V, Miossec P (2012) Combination of IL-17 and TNFalpha induces a pro-inflammatory, pro-coagulant and pro-thrombotic phenotype in human endothelial cells. Ann Rheum Dis 71:768–776. https://doi.org/10.1136/annrheumdis-2011-200468

Article  CAS  PubMed  Google Scholar 

Gao Q, Jiang Y, Ma T, Zhu F, Gao F, Zhang P, Guo C, Wang Q et al (2010) A critical function of Th17 proinflammatory cells in the development of atherosclerotic plaque in mice. J Immunol 185:5820–5827. https://doi.org/10.4049/jimmunol.1000116

Article  CAS  PubMed  Google Scholar 

Wang Y, Li W, Zhao T, Zou Y, Deng T, Yang Z, Yuan Z, Ma L et al (2021) Interleukin-17-producing CD4(+) T cells promote inflammatory response and foster disease progression in hyperlipidemic patients and atherosclerotic mice. Front Cardiovasc Med 8:667768. https://doi.org/10.3389/fcvm.2021.667768

Article  CAS  PubMed  PubMed Central